Boston biotech Gelesis aims to crack the weight-loss market with new pill The Boston Globe
Gelesis, a 13-year-old Boston biotech, hopes it will succeed in the marketplace where other drug makers haven’t: for weight-loss drugs.
Brought to you by Google News. Read the rest of the article here.